BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26545880)

  • 1. Neuropsychological Development in Patients with Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase (LCHAD) Deficiency.
    Strandqvist A; Haglind CB; Zetterström RH; Nemeth A; von Döbeln U; Stenlid MH; Nordenström A
    JIMD Rep; 2016; 28():75-84. PubMed ID: 26545880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodevelopmental profiles of children with very long chain acyl-CoA dehydrogenase deficiency diagnosed by newborn screening.
    Brown A; Crowe L; Andresen BS; Anderson V; Boneh A
    Mol Genet Metab; 2014 Dec; 113(4):278-82. PubMed ID: 25456746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes and genotype correlations in patients with mitochondrial trifunctional protein or isolated long chain 3-hydroxyacyl-CoA dehydrogenase deficiency enrolled in the IBEM-IS database.
    Lim CC; Vockley J; Ujah O; Kirby RS; Edick MJ; Berry SA; Arnold GL
    Mol Genet Metab Rep; 2022 Sep; 32():100884. PubMed ID: 35677112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary management of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD). A case report and survey.
    Gillingham M; Van Calcar S; Ney D; Wolff J; Harding C
    J Inherit Metab Dis; 1999 Apr; 22(2):123-31. PubMed ID: 10234607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal pitfalls in newborn screening for mitochondrial trifunctional protein (MTP)/long-chain 3-Hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency.
    Lotz-Havla AS; Röschinger W; Schiergens K; Singer K; Karall D; Konstantopoulou V; Wortmann SB; Maier EM
    Orphanet J Rare Dis; 2018 Jul; 13(1):122. PubMed ID: 30029694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-chain fatty acid oxidation during early human development.
    Oey NA; den Boer ME; Wijburg FA; Vekemans M; Augé J; Steiner C; Wanders RJ; Waterham HR; Ruiter JP; Attié-Bitach T
    Pediatr Res; 2005 Jun; 57(6):755-9. PubMed ID: 15845636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and genetic characteristics of patients with fatty acid oxidation disorders identified by newborn screening.
    Kang E; Kim YM; Kang M; Heo SH; Kim GH; Choi IH; Choi JH; Yoo HW; Lee BH
    BMC Pediatr; 2018 Mar; 18(1):103. PubMed ID: 29519241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular basis of pediatric long chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy.
    Sims HF; Brackett JC; Powell CK; Treem WR; Hale DE; Bennett MJ; Gibson B; Shapiro S; Strauss AW
    Proc Natl Acad Sci U S A; 1995 Jan; 92(3):841-5. PubMed ID: 7846063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of 3-hydroxy-fatty acids in the culture medium of long-chain L-3-hydroxyacyl CoA dehydrogenase (LCHAD) and mitochondrial trifunctional protein-deficient skin fibroblasts: implications for medium chain triglyceride dietary treatment of LCHAD deficiency.
    Jones PM; Butt Y; Bennett MJ
    Pediatr Res; 2003 May; 53(5):783-7. PubMed ID: 12621125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Variation of long-chain 3-hydroxyacyl-CoA dehydrogenase DNA methylation in placenta of different preeclampsia-like mouse models].
    Han Y; Yang Z; Ding X; Yu H; Yi Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Oct; 50(10):740-6. PubMed ID: 26675572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients.
    den Boer ME; Wanders RJ; Morris AA; IJlst L; Heymans HS; Wijburg FA
    Pediatrics; 2002 Jan; 109(1):99-104. PubMed ID: 11773547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial fatty acid beta-oxidation in the human eye and brain: implications for the retinopathy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
    Tyni T; Paetau A; Strauss AW; Middleton B; Kivelä T
    Pediatr Res; 2004 Nov; 56(5):744-50. PubMed ID: 15347768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal COVID-19 infection in a patient with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: A case report.
    Wongkittichote P; Watson JR; Leonard JM; Toolan ER; Dickson PI; Grange DK
    JIMD Rep; 2020 Nov; 56(1):40-45. PubMed ID: 33204595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
    Tyni T; Pihko H
    Acta Paediatr; 1999 Mar; 88(3):237-45. PubMed ID: 10229030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of LCHAD/TFP deficiency in an at risk newborn using umbilical cord blood acylcarnitine analysis.
    Raval DB; Cusmano-Ozog KP; Ayyub O; Jenevein C; Kofman LH; Lanpher B; Hauser N; Regier DS
    Mol Genet Metab Rep; 2017 Mar; 10():8-10. PubMed ID: 27995076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-Specific Induced Pluripotent Stem Cell-Derived RPE Cells: Understanding the Pathogenesis of Retinopathy in Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency.
    Polinati PP; Ilmarinen T; Trokovic R; Hyotylainen T; Otonkoski T; Suomalainen A; Skottman H; Tyni T
    Invest Ophthalmol Vis Sci; 2015 May; 56(5):3371-82. PubMed ID: 26024122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral neuropathy in patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency - A follow-up EMG study of 12 patients.
    Immonen T; Ahola E; Toppila J; Lapatto R; Tyni T; Lauronen L
    Eur J Paediatr Neurol; 2016 Jan; 20(1):38-44. PubMed ID: 26653362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute fatty liver of pregnancy, hemolysis, elevated liver enzymes, and low platelets syndrome, and long chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency.
    Treem WR; Shoup ME; Hale DE; Bennett MJ; Rinaldo P; Millington DS; Stanley CA; Riely CA; Hyams JS
    Am J Gastroenterol; 1996 Nov; 91(11):2293-300. PubMed ID: 8931405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Variation of long-chain 3-hydroxyacyl CoA dehydrogenase DNA methylated modification and correlation with gene mRNA expression of early-onset preeclampsia, HELLP syndrome and antiphospholipid syndrome in trophoblast cells of placenta].
    Meng R; Yang Z; Wang HL; Han YW; Wang YL; Yu H
    Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):270-8. PubMed ID: 27116985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of correlation between fatty acid oxidation disorders and haemolysis, elevated liver enzymes, low platelets (HELLP) syndrome?
    Holub M; Bodamer OA; Item C; Mühl A; Pollak A; Stöckler-Ipsiroglu S
    Acta Paediatr; 2005 Jan; 94(1):48-52. PubMed ID: 15858960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.